Completed PHASE4 INTERVENTIONAL 2-arm NCT00786370

Dexmedetomidine vs. Propofol for Cataract Surgery

Dexmedetomidine vs. Propofol for Monitored Anesthesia Care During Cataract

Sponsor: The Cooper Health System

Conditions Cataract

Interventions Dexemedetomidine Propofol dexmedetomidine

Updated 5 times since 2017 Last updated: Feb 9, 2012 Started: Apr 30, 2008 Primary completion: Apr 30, 2010 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cataract, this trial is completed. The trial is conducted by The Cooper Health System and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Cooper Health System

Data source: The Cooper Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Camden, United States